Moloney Securities Asset Management, LLC Bristol Myers Squibb CO Transaction History

Moloney Securities Asset Management, LLC

$714 Million
Q3 2024

A detailed history of Moloney Securities Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 16,284 shares of BMY stock, worth $944,472. This represents 0.12% of its overall portfolio holdings.

Number of Shares

16,284

Previous 21,684 24.9%

Holding current value

$944,472

Previous $900,000 6.44%

% of portfolio

0.12%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$39.66 - $51.75 $214,163 - $279,450	-5,400 Reduced 24.9%	16,284 $842,000
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $110,969 - $146,093	-2,757 Reduced 11.28%	21,684 $900,000
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $177,765 - $201,552	-3,705 Reduced 13.16%	24,441 $1.33 Million
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $14,107 - $16,834	291 Added 1.04%	28,146 $1.44 Million
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $96,328 - $107,710	-1,664 Reduced 5.64%	27,855 $1.62 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $65,430 - $72,649	-1,027 Reduced 3.36%	29,519 $1.89 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $43,368 - $49,189	-660 Reduced 2.11%	30,546 $2.12 Million
Q4 2022 Jan 30, 2023	SELL	$68.48 - $81.09 $629,810 - $745,784	-9,197 Reduced 22.76%	31,206 $2.24 Million
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $71 - $42,415	-552 Reduced 1.35%	40,403 $2.87 Million
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $675,946 - $744,453	9,308 Added 29.41%	40,955 $3.15 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $63,939 - $76,668	1,040 Added 3.4%	31,647 $2.31 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $123,885 - $144,421	-2,310 Reduced 7.02%	30,607 $1.91 Million
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $449,159 - $526,132	-7,591 Reduced 18.74%	32,917 $1.95 Million
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $373,812 - $407,081	-6,038 Reduced 12.97%	40,508 $2.71 Million
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $934,011 - $1.05 Million	15,740 Added 51.09%	46,546 $2.94 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $277,267 - $314,194	-4,802 Reduced 13.49%	30,806 $1.91 Million
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $587,738 - $651,291	10,234 Added 40.33%	35,608 $2.15 Million
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $12,444 - $14,548	227 Added 0.9%	25,374 $1.49 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $371 - $539	8 Added 0.03%	25,147 $1.4 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $229,121 - $298,868	4,656 Added 22.73%	25,139 $1.61 Million
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $198,966 - $235,902	-4,652 Reduced 18.51%	20,483 $1.04 Million
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $28,824 - $31,873	-646 Reduced 2.51%	25,135 $1.14 Million
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $167,846 - $200,136	3,720 Added 16.86%	25,781 $1.23 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $117,316 - $152,131	-2,406 Reduced 9.83%	22,061 $1.15 Million
Q3 2018 Oct 24, 2018	SELL	$55.19 - $62.25 $107,399 - $121,138	-1,946 Reduced 7.37%	24,467 $0
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $490,039 - $610,780	-9,698 Reduced 26.86%	26,413 $1.46 Million
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $27,143 - $31,247	-453 Reduced 1.24%	36,111 $2.28 Million
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $108,431 - $118,218	-1,809 Reduced 4.71%	36,564 $2.24 Million
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $2.12 Million - $2.45 Million	38,373	38,373 $2.45 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account

Moloney Securities Asset Management, LLC Bristol Myers Squibb CO Transaction History